Welcome to LookChem.com Sign In|Join Free

CAS

  • or
6-BROMO-8-METHOXYQUINAZOLIN-2-OL is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

953039-13-9

Post Buying Request

953039-13-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

953039-13-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 953039-13-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,5,3,0,3 and 9 respectively; the second part has 2 digits, 1 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 953039-13:
(8*9)+(7*5)+(6*3)+(5*0)+(4*3)+(3*9)+(2*1)+(1*3)=169
169 % 10 = 9
So 953039-13-9 is a valid CAS Registry Number.

953039-13-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 6-bromo-8-methoxy-1H-quinazolin-2-one

1.2 Other means of identification

Product number -
Other names 6-BROMO-8-METHOXYQUINAZOLIN-2-OL

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:953039-13-9 SDS

953039-13-9Relevant articles and documents

CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS

-

, (2018/03/09)

Chemical entities that are kinase inhibitors, pharmaceutical compositions and methods of treatment of cancer are described.

NEW CHEMICAL COMPOUNDS

-

Page/Page column 78-79, (2010/04/03)

The present invention encompasses compounds of general formula (1) while the groups R4 to R7 and the units W, L, Qa and QH are defined as in claim 1, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, and their use as medicaments having the above-mentioned properties.

NEW CHEMICAL COMPOUNDS

-

Page/Page column 113, (2010/04/03)

The present invention encompasses compounds of general formula (1) wherein the units W, A, L, Q1 and QH are defined as in claim 1, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, and their use as medicaments having the above-mentioned properties.

QUINAZOLINES FOR PDK1 INHIBITION

-

, (2008/06/13)

The invention provides novel quinazoline compounds that are inhibitors of PDK1. Also provided are pharmaceutical compositions including the compounds, and methods of treating proliferative diseases, such as cancers, with the compounds or compositions.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 953039-13-9